Template:Infobox drug/testcases8

|type= vaccine/combo/mab/blank

Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM

/sandbox: {{Drugbox}} · {{title}} ·  · src {{licence}} ·  · src {{legal}} ·  · src {{pregcat}} ·  · src {{molarmass}} ·  · src {{mab source}} ·  · src {{localINNvar}} ·  · src {{maint cat}} ·  · src {{fmtATC}} ·  · src /format · Infobox drug/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit) FDA-2023 {{Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023  · /sandbox2 parameters Full parameter list () · Type-conditional sections TPU cats:Category:Infobox drug tracking categories (32): Category:Pages using infobox drug with unknown parameters (12) · Parameter usage report cat:IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{cascite}} chembox {{Chem/dev/nav}} · {{Chembox}} Infobox drug class/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit)

all/check

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
all_all	all_all

blank

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
blank Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	blank Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

IUPAC

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
blank w/IUPACname Pharmacokinetic data Bioavailability bioavail Identifiers IUPAC name iupac-name Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	blank w/IUPACname Pharmacokinetic data Bioavailability bioavail Identifiers IUPAC name iupac-name Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

mab

mab = data10; source=data11, target=data12 (freetext)

mab, source

| mab = Whole antibody | fab = [[Fab fragment]] | f(ab')2 = [[F(ab')2 fragment|F(ab')<sub>2</sub> fragment]] | fab' = [[Fab' fragment]] | scfv = [[Single-chain variable fragment]] | discfv = Di-[[single-chain variable fragment]] | sdab = [[Single domain antibody]] | 3funct = [[Trifunctional antibody]] | clfab = [[Chemically linked Fab]] | bite = [[Bi-specific T-cell engager]] | ? if mab= then use source= | label11 = [[Monoclonal antibody#Production|Source]] | data11 = {{#ifeq: {{{type|}}} | mab | {{#switch: {{lc:{{{source|}}}}} | = | a = [[Rat]] | e = [[Hamster]] | i = [[Primate]] | o = [[Mouse]] | u = [[Human]] | xi/a = [[chimeric antibody|Chimeric]] ([[rat]]/[[human]]) | xi/e = [[chimeric antibody|Chimeric]] ([[hamster]]/[[human]]) | xi/i = [[chimeric antibody|Chimeric]] ([[primate]]/[[human]]) | xi/o = [[chimeric antibody|Chimeric]] ([[mouse]]/[[human]]) | xi = [[chimeric antibody|Chimeric]] | zu/a = [[Humanized]] (from [[rat]]) | zu/e = [[Humanized]] (from [[hamster]]) | zu/i = [[Humanized]] (from [[primate]]) | zu/o = [[Humanized]] (from [[mouse]]) | zu = [[Humanized]] | xizu/a = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[rat]]/[[human]]) | xizu/e = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[hamster]]/[[human]]) | xizu/i = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[primate]]/[[human]]) | xizu/o = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[mouse]]/[[human]]) | xizu = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid | axo = [[Rat]]/[[mouse]] hybrid | {{{source|}}} [[:Category:Drugboxes with unformatted antibody source]]

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Monoclonal antibody Type ? Clinical data AHFS/Drugs.com Monograph MedlinePlus a602026 Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 NIAID ChemDB 007686 Chemical and physical data Formula chem_form Molar mass 877.031 g/mol Melting point 100 °C (212 °F)	Infobox drug/testcases8 Monoclonal antibody Type ? Clinical data AHFS/Drugs.com Monograph MedlinePlus a602026 Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 NIAID ChemDB 007686 Chemical and physical data Formula chem_form Molar mass 877.031 g/mol Melting point 100 °C (212 °F)

combo

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
combo Combination of c1 ? Class c2 ? Class Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	combo Combination of c1 ? Class c2 ? Class Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
combo5 Combination of c1 cl1 c2 c2 c4 cl4 c5 cl5 Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	combo5 Combination of c1 cl1 c2 c2 c4 cl4 c5 cl5 Pharmacokinetic data Bioavailability bioavail Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

vaccine

|vaccin_type=

 |killed |inactivated = Killed/Inactivated
 |attenuated = [[Attenuated virus]]
 |live = Live bacteria
 |toxoid = [[Toxoid]]
 |subunit = Subunit
 |protein subunit |protein = [[Protein subunit]]
 |conjugate=[[Conjugate vaccine]]
 |recombinant = [[Recombinant DNA|Recombinant Vector]]
 |dna = [[DNA vaccination]]
 | ?

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
vaccine w/target Vaccine description Target _target_ Vaccine type Attenuated Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	vaccine w/target Vaccine description Target _target_ Vaccine type Attenuated Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
vaccine, no target Vaccine description Vaccine type Attenuated Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)	vaccine, no target Vaccine description Vaccine type Attenuated Pharmacokinetic data Bioavailability increases when administered with food Identifiers CAS Number 61379-65-5 Chemical and physical data Formula chem_form Melting point 100 °C (212 °F)

Licence

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases8 INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 ChemSpider 390139 Y UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases8 INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 ChemSpider 390139 Y UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

English language variants: Licence or License

See also WP:ENGVAR: english language variant of the article

In {{Infobox drug}}: spelling of licence/license. Default is to be en-US: License.

Use new parameter |engvar= for non-default spelling:

Default licenSe (US)

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
demo Clinical data License data US FDA: C	demo Clinical data License data US FDA: C

|engvar=en-US licenSe

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
demo Clinical data License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid	demo Clinical data License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid

|engvar=en-UK licenCe

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
demo Clinical data Licence data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid	demo Clinical data Licence data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid

|engvar=en-NZ licenCe

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
demo Clinical data Licence data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid	demo Clinical data Licence data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid

Titletests

The infobox title is a logical result of input:

• {{PAGENAME}} (default)
• |drug_name= (overwrites, eg when PAGENAME is not the INN drugname)
• |INN= (added, when PAGENAME/drug_name is not the INN name)

See Category:Infobox drug articles with non-default infobox title (837)

?

(reduced infobox)

Current infobox title: Diamorphine (INN)

The new situation required an edit.

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Heroin INN: Diamorphine Clinical data Pronunciation /ˈhɛroʊɪn/ Other names Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate AHFS/Drugs.com heroin Dependence liability Physical: Very high Psychological: Very high Addiction liability Very high Routes of administration Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular ATC code N07BC06 (WHO) Legal status Legal status AU: S9 (Prohibited substance) Identifiers IUPAC name (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate CAS Number 561-27-3 Y PubChem CID 5462328 DrugBank DB01452 Y ChemSpider 4575379 Y UNII 8H672SHT8E ChEBI CHEBI:27808 Y ChEMBL ChEMBL459324 Y Chemical and physical data Formula C21H23NO5 Molar mass 369.41 g/mol g·mol−1

Heroin INN: Diamorphine Clinical data Pronunciation /ˈhɛroʊɪn/ Other names Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate AHFS/Drugs.com heroin Dependence liability Physical: Very high Psychological: Very high Addiction liability Very high Routes of administration Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular ATC code N07BC06 (WHO) Legal status Legal status AU: S9 (Prohibited substance) Identifiers IUPAC name (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate CAS Number 561-27-3 Y PubChem CID 5462328 DrugBank DB01452 Y ChemSpider 4575379 Y UNII 8H672SHT8E ChEBI CHEBI:27808 Y ChEMBL ChEMBL459324 Y Chemical and physical data Formula C21H23NO5 Molar mass 369.41 g/mol g·mol−1

Lysergide (LSD)

Reduced infobox.

Current infobox title: Lysergic acid diethylamide (pagename, not INN)

New situation would be (adding "(LSD)" is just a liberty I took, to help our readers):

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Lysergic acid diethylamide (LSD) INN: Lysergide Clinical data Other names Acid, LSD, lysergide Dependence liability Low Addiction liability None Routes of administration Oral, etc ATC code none Legal status Legal status AU: S9 (Prohibited substance) CA: Schedule III DE: Anlage I (Authorized scientific use only) NZ: Class A UK: Class A US: Schedule I UN: Psychotropic Schedule I Pharmacokinetic data Metabolism Hepatic Elimination half-life 3–5 hours Excretion Renal Identifiers IUPAC name (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide CAS Number 50-37-3 PubChem CID 5761 IUPHAR/BPS 17 DrugBank DB04829 ChemSpider 5558 UNII 8NA5SWF92O ChEBI CHEBI:6605 ChEMBL ChEMBL263881 Chemical and physical data Formula C20H25N3O Molar mass 323.440 g·mol−1

Lysergic acid diethylamide (LSD) INN: Lysergide Clinical data Other names Acid, LSD, lysergide Dependence liability Low Addiction liability None Routes of administration Oral, etc ATC code none Legal status Legal status AU: S9 (Prohibited substance) CA: Schedule III DE: Anlage I (Authorized scientific use only) NZ: Class A UK: Class A US: Schedule I UN: Psychotropic Schedule I Pharmacokinetic data Metabolism Hepatic Elimination half-life 3–5 hours Excretion Renal Identifiers IUPAC name (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide CAS Number 50-37-3 PubChem CID 5761 IUPHAR/BPS 17 DrugBank DB04829 ChemSpider 5558 UNII 8NA5SWF92O ChEBI CHEBI:6605 ChEMBL ChEMBL263881 Chemical and physical data Formula C20H25N3O Molar mass 323.440 g·mol−1

(regular)

• alpha-Methyltryptamine

No need to use |INN=. Note the titletext (mousehover).

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
α-Methyltryptamine Clinical data Other names Indopan; IT-290, IT-403, U-14,164E, 3-IT Routes of administration Oral ATC code none Identifiers IUPAC name 2-(1H-indol-3-yl)-1-methyl-ethylamine CAS Number 299-26-3 Chemical and physical data Formula C11H14N2 Molar mass 174.247 g·mol−1	α-Methyltryptamine Clinical data Other names Indopan; IT-290, IT-403, U-14,164E, 3-IT Routes of administration Oral ATC code none Identifiers IUPAC name 2-(1H-indol-3-yl)-1-methyl-ethylamine CAS Number 299-26-3 Chemical and physical data Formula C11H14N2 Molar mass 174.247 g·mol−1

Title

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Aspirin Identifiers CAS Number 1234-56-7	Aspirin Identifiers CAS Number 1234-56-7

INN

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Aspirin MP INN: inn Identifiers CAS Number 1234-56-7	Aspirin MP INN: inn Identifiers CAS Number 1234-56-7

INN=none

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Aspirin Identifiers CAS Number 1234-56-7	Aspirin Identifiers CAS Number 1234-56-7

INN=sense

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: inn Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Aspirin INN: inn Identifiers CAS Number 1234-56-7	Aspirin INN: inn Identifiers CAS Number 1234-56-7

INN='none'

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Aspirin Identifiers CAS Number 1234-56-7	Aspirin Identifiers CAS Number 1234-56-7

INN eq

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8 INN: Infobox drug/testcases8 Identifiers CAS Number 1234-56-7	Infobox drug/testcases8 INN: Infobox drug/testcases8 Identifiers CAS Number 1234-56-7

all

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases8	Infobox drug/testcases8